79 related articles for article (PubMed ID: 7794701)
1. Nizatidine versus placebo in gastro-oesophageal reflux disease: a 12-week, multicentre, randomised, double-blind study.
Cloud ML; Offen WW; Robinson M
Br J Clin Pract Suppl; 1994 Nov; 76():3-10. PubMed ID: 7794701
[TBL] [Abstract][Full Text] [Related]
2. Nizatidine versus placebo in gastroesophageal reflux disease: a 12-week, multicenter, randomized, double-blind study.
Cloud ML; Offen WW; Robinson M
Am J Gastroenterol; 1991 Dec; 86(12):1735-42. PubMed ID: 1962618
[TBL] [Abstract][Full Text] [Related]
3. Nizatidine versus placebo in gastro-oesophageal reflux disease: a 6-week, multicentre, randomised, double-blind comparison. Nizatidine Gastroesophageal Reflux Disease Study Group.
Cloud ML; Offen WW
Br J Clin Pract Suppl; 1994 Nov; 76():11-9. PubMed ID: 7794700
[TBL] [Abstract][Full Text] [Related]
4. Treatment of erosive reflux oesophagitis: a double-blind multicentre trial with nizatidine 300 mg b.i.d. versus placebo.
Dobrilla G; Chilovi F; Tafner G; Vantini I; Bernardi A; Gentilini R; Fedrizzi F; Manfrini R; Steiner H; Mon M
Ital J Gastroenterol; 1992; 24(6):338-41. PubMed ID: 1515660
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the efficacy of pantoprazole vs. nizatidine in the treatment of erosive oesophagitis: a randomized, active-controlled, double-blind study.
Kovacs TO; Wilcox CM; DeVault K; Miska D; Bochenek W;
Aliment Pharmacol Ther; 2002 Dec; 16(12):2043-52. PubMed ID: 12452936
[TBL] [Abstract][Full Text] [Related]
6. Nizatidine for the treatment of pediatric gastroesophageal reflux symptoms: an open-label, multiple-dose, randomized, multicenter clinical trial in 210 children.
Orenstein SR; Gremse DA; Pantaleon CD; Kling DF; Rotenberg KS
Clin Ther; 2005 Apr; 27(4):472-83. PubMed ID: 15922820
[TBL] [Abstract][Full Text] [Related]
7. [Symptomatic therapy with famotidine in non-erosive gastro-esophageal reflux. Results of an open multicenter study].
Heckers H; Lübbecke F
Arzneimittelforschung; 1995 Apr; 45(4):499-504. PubMed ID: 7779150
[TBL] [Abstract][Full Text] [Related]
8. Nizatidine versus placebo in gastroesophageal reflux disease. A six-week, multicenter, randomized, double-blind comparison. Nizatidine Gastroesophageal Reflux Disease Study Group.
Cloud ML; Offen WW
Dig Dis Sci; 1992 Jun; 37(6):865-74. PubMed ID: 1587191
[TBL] [Abstract][Full Text] [Related]
9. Famotidine relieves symptoms of gastroesophageal reflux disease and heals erosions and ulcerations. Results of a multicenter, placebo-controlled, dose-ranging study. USA Merck Gastroesophageal Reflux Disease Study Group.
Sabesin SM; Berlin RG; Humphries TJ; Bradstreet DC; Walton-Bowen KL; Zaidi S
Arch Intern Med; 1991 Dec; 151(12):2394-400. PubMed ID: 1746996
[TBL] [Abstract][Full Text] [Related]
10. Cimetidine QID and BID in rapid heartburn relief and healing of lesions in gastroesophageal reflux disease.
Palmer RH; Miller DM; Hedrich DA; Karlstadt RG
Clin Ther; 1993; 15(6):994-1001. PubMed ID: 8111819
[TBL] [Abstract][Full Text] [Related]
11. The effect of an empirical trial of high-dose lansoprazole on symptom response of patients with non-cardiac chest pain--a randomized, double-blind, placebo-controlled, crossover trial.
Bautista J; Fullerton H; Briseno M; Cui H; Fass R
Aliment Pharmacol Ther; 2004 May; 19(10):1123-30. PubMed ID: 15142202
[TBL] [Abstract][Full Text] [Related]
12. A double-blind, placebo-controlled study of the effectiveness and safety of nizatidine in the prevention of postprandial heartburn.
Spiegel JE; Thoden WR; Pappas K; Fratarcangelo P; Furey SA
Arch Intern Med; 1997 Jul; 157(14):1594-9. PubMed ID: 9236562
[TBL] [Abstract][Full Text] [Related]
13. Gastro-oesophageal reflux disease in primary care: an international study of different treatment strategies with omeprazole. International GORD Study Group.
Carlsson R; Dent J; Watts R; Riley S; Sheikh R; Hatlebakk J; Haug K; de Groot G; van Oudvorst A; Dalväg A; Junghard O; Wiklund I
Eur J Gastroenterol Hepatol; 1998 Feb; 10(2):119-24. PubMed ID: 9581986
[TBL] [Abstract][Full Text] [Related]
14. Comparison of 150 mg nizatidine BID or 300 mg at bedtime, and 150 mg ranitidine BID in the treatment of gastric ulcer--an 8-week randomized, double-blind multicentre study.
Di Mario F; Battaglia G; Naccarato R; D'Angelo A; Saggioro A; Da Broi GL; Vezzadini P; Bianchi Porro G
Hepatogastroenterology; 1990 Dec; 37 Suppl 2():62-5. PubMed ID: 1982108
[TBL] [Abstract][Full Text] [Related]
15. Pathophysiological characteristics of the various forms of gastro-oesophageal reflux disease. Spectrum disease or distinct phenotypic presentations?
Frazzoni M; Manno M; De Micheli E; Savarino V
Dig Liver Dis; 2006 Sep; 38(9):643-8. PubMed ID: 16627016
[TBL] [Abstract][Full Text] [Related]
16. Nizatidine versus placebo in active benign gastric ulcer disease: an eight-week, multicenter, randomized, double-blind comparison. The Nizatidine Benign Gastric Ulcer Disease Study Group.
Cloud ML; Enas N; Offen WW
Clin Pharmacol Ther; 1992 Sep; 52(3):307-13. PubMed ID: 1526089
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of famotidine and omeprazole in healing symptoms of non-erosive gastro-oesophageal reflux disease: randomized-controlled study of gastro-oesophageal reflux disease.
Wada T; Sasaki M; Kataoka H; Tanida S; Itoh K; Ogasawara N; Oshima T; Togawa S; Kubota E; Yamada T; Mori Y; Fujita F; Ohara H; Nakao H; Sobue S; Joh T; Itoh M
Aliment Pharmacol Ther; 2005 Jun; 21 Suppl 2():2-9. PubMed ID: 15943840
[TBL] [Abstract][Full Text] [Related]
18. Famotidine vs. omeprazole: a prospective randomized multicentre trial to determine efficacy in non-erosive gastro-oesophageal reflux disease.
Fujiwara Y; Higuchi K; Nebiki H; Chono S; Uno H; Kitada K; Satoh H; Nakagawa K; Kobayashi K; Tominaga K; Watanabe T; Oshitani N; Arakawa T
Aliment Pharmacol Ther; 2005 Jun; 21 Suppl 2():10-8. PubMed ID: 15943841
[TBL] [Abstract][Full Text] [Related]
19. Double-blind, placebo-controlled study of ranitidine for gastroesophageal reflux symptoms during pregnancy.
Larson JD; Patatanian E; Miner PB; Rayburn WF; Robinson MG
Obstet Gynecol; 1997 Jul; 90(1):83-7. PubMed ID: 9207819
[TBL] [Abstract][Full Text] [Related]
20. Short and long-term effect of two different dosages of ranitidine in the therapy of reflux oesophagitis.
Pace F; Sangaletti O; Bianchi Porro G
Ital J Gastroenterol; 1990 Feb; 22(1):28-32. PubMed ID: 2131925
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
